Eventide combines faith-based and socially responsible investing across its mutual fund lineup, where nearly all the firm's assets lie. Eventide’s Business 360 social screening is thorough, though the firm’s funds don’t always measure up by standard sustainability metrics given their focus on smaller companies with less publicly available information. Co-founder Finny Kuruvilla manages the firm’s largest two funds — Eventide Gilead and Eventide Healthcare and Life Sciences — and remains the firm’s largest owner, though more than 20 of the firm's 78 employees(as of August 2023) have ownership stakes in the firm.
Eventide greatly expanded its distribution and investment teams after launching a growth effort in 2019, but there has been a fair amount of turnover in the investment ranks since then. Between February 2020 and September 2021 the firm's assets under management doubled to $8.8 billion before falling back to $6.8 billion as of September 2023. Despite this growth, Gilead and Healthcare & Life Sciences continue to hold the lion’s share of the firm’s assets, potentially concerning given their volatile performance patterns. The firm could also do more to pass cost savings to its investors, as nearly all its funds have significantly higher fees than their peers.